(VIANEWS) – MercadoLibre (MELI), Amphastar Pharmaceuticals (AMPH), New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share (EDU) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MercadoLibre (MELI)
35.2% sales growth and 45.15% return on equity
MercadoLibre, Inc. operates online commerce platforms in Latin America. It operates Mercado Libre Marketplace, an automated online commerce platform that enables businesses, merchants, and individuals to list merchandise and conduct sales and purchases online; and Mercado Pago FinTech platform, a financial technology solution platform, which facilitates transactions on and off its marketplaces by providing a mechanism that allows its users to send and receive payments online, as well as allows users to transfer money through their websites or on the apps. The company also offers Mercado Fondo that allows users to invest funds deposited in their Mercado Pago accounts; Mercado Credito, which extends loans to certain merchants and consumers; and Mercado Envios logistics solution that enables sellers on its platform to utilize third-party carriers and other logistics service providers, as well as fulfillment and warehousing services for sellers. In addition, it provides Mercado Libre Classifieds, an online classified listing service, where users can list and purchase motor vehicles, real estate, and services; Mercado Libre Ads, an advertising platform, which enables large retailers and brands to promote their products and services on the web; and Mercado Shops, an online storefronts solution that enables users to set-up, manage, and promote their own digital stores. The company was incorporated in 1999 and is headquartered in Montevideo, Uruguay.
Earnings Per Share
As for profitability, MercadoLibre has a trailing twelve months EPS of $19.62.
PE Ratio
MercadoLibre has a trailing twelve months price to earnings ratio of 88.36. Meaning, the purchaser of the share is investing $88.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.15%.
Previous days news about MercadoLibre(MELI)
- According to Zacks on Monday, 12 February, "And when it comes to top line strength, three companies - MercadoLibre (MELI Quick QuoteMELI – Free Report) , Amazon (AMZN Quick QuoteAMZN – Free Report) , and OneSpaWorld (OSW Quick QuoteOSW – Free Report) - have all grown their sales considerably over the recent years.", "And when it comes to strong revenue trends, all three companies above - MercadoLibre (MELI Quick QuoteMELI – Free Report) , Amazon (AMZN Quick QuoteAMZN – Free Report) , and OneSpaWorld (OSW Quick QuoteOSW – Free Report) - precisely fit the criteria."
- Why mercadolibre (meli) dipped more than broader market today. According to Zacks on Tuesday, 13 February, "The investment community will be closely monitoring the performance of MercadoLibre in its forthcoming earnings report. ", "Valuation is also important, so investors should note that MercadoLibre has a Forward P/E ratio of 49.12 right now. "
2. Amphastar Pharmaceuticals (AMPH)
34% sales growth and 24.59% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $2.56.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 21.05. Meaning, the purchaser of the share is investing $21.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.59%.
Yearly Top and Bottom Value
Amphastar Pharmaceuticals’s stock is valued at $53.88 at 19:22 EST, way under its 52-week high of $67.66 and way above its 52-week low of $29.91.
Revenue Growth
Year-on-year quarterly revenue growth grew by 50.3%, now sitting on 601.31M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Amphastar Pharmaceuticals’s EBITDA is 28.74.
Previous days news about Amphastar Pharmaceuticals(AMPH)
- According to Zacks on Wednesday, 14 February, "Taking into account individual holdings, Amphastar Pharmaceuticals Inc (AMPH Quick QuoteAMPH – Free Report) accounts for about 3.45% of the fund’s total assets, followed by Westlake Corporation (WLK Quick QuoteWLK – Free Report) and Amkor Technology Inc (AMKR Quick QuoteAMKR – Free Report) ."
3. New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share (EDU)
27.4% sales growth and 8.8% return on equity
New Oriental Education & Technology Group Inc. provides private educational services under the New Oriental brand in the People's Republic of China. It operates through K-12 AST, Test Preparation and Other Courses; and Others segments. The company offers test preparation courses to students taking language and entrance exams used by educational institutions in the United States, the People's Republic of China, and the Commonwealth countries; and after-school tutoring courses for middle and high school students to enhance their exam scores, as well as for children to teach English. It also provides language training courses, including English, as well as other foreign languages, such as German, Japanese, French, Korean, Italian, and Spanish; operates a full-time private primary and secondary school in Yangzhou seeking a full curriculum with a focus on English; develops and edits educational materials for language training and test preparation; and offers online education programs that include college, K-12, and pre-school education. In addition, the company offers overseas studies consulting and overseas study tour services. As of May 31, 2020, it offered educational programs, services, and products to students through a network of 104 schools, 1,361 learning centers, and 12 bookstores. The company was founded in 1993 and is headquartered in Beijing, the People's Republic of China.
Earnings Per Share
As for profitability, New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share has a trailing twelve months EPS of $1.8.
PE Ratio
New Oriental Education & Technology Group Sponsored ADR representing 1 Ordinary Share has a trailing twelve months price to earnings ratio of 48.88. Meaning, the purchaser of the share is investing $48.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.8%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 1200% and 73%, respectively.
4. Golar LNG Limited (GLNG)
17.9% sales growth and 3.36% return on equity
Golar LNG Limited designs, builds, owns, and operates marine infrastructure for the liquefaction and regasification of LNG. It operates through Shipping and FLNG segments. The company engages in the operation and chartering of LNG carriers, Floating Liquefaction Natural Gas Vessel (FLNG), and floating storage regasification units (FSRUs), as well as operates external vessels. As of December 31, 2021, it operated nine LNG carriers, one FSRU, and three FLNGs. The company was founded in 1946 and is headquartered in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Golar LNG Limited has a trailing twelve months EPS of $0.51.
PE Ratio
Golar LNG Limited has a trailing twelve months price to earnings ratio of 44.24. Meaning, the purchaser of the share is investing $44.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.36%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 26.6% and positive 44% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.7%, now sitting on 277.89M for the twelve trailing months.
Sales Growth
Golar LNG Limited’s sales growth is 33.9% for the ongoing quarter and 17.9% for the next.
5. The Ensign Group (ENSG)
11.3% sales growth and 18.78% return on equity
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Earnings Per Share
As for profitability, The Ensign Group has a trailing twelve months EPS of $4.34.
PE Ratio
The Ensign Group has a trailing twelve months price to earnings ratio of 26.85. Meaning, the purchaser of the share is investing $26.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.78%.
6. Cass Information Systems (CASS)
8.6% sales growth and 13.78% return on equity
Cass Information Systems, Inc. provides payment and information processing services to manufacturing, distribution, and retail enterprises in the United States. It operates through two segments, Information Services and Banking Services. The company's services include freight invoice rating, payment processing, auditing, and the generation of accounting and transportation information. It also processes and pays facility-related invoices, such as electricity, gas, waste, and telecommunications expenses; and provides telecom expense management solutions. In addition, the company, through its banking subsidiary, Cass Commercial Bank, provides a range of banking products and services, such as checking, savings, and time deposit accounts; commercial, industrial, and real estate loans; and cash management services to privately-owned businesses and faith-related ministries. Further, it provides B2B payment platform for clients that require an agile fintech partner. It operates through its banking facility near downtown St. Louis, Missouri; operating branch in the Bridgeton, Missouri; and leased facilities in Fenton, Missouri and Colorado Springs, Colorado. The company was formerly known as Cass Commercial Corporation and changed its name to Cass Information Systems, Inc. in January 2001. Cass Information Systems, Inc. was founded in 1906 and is headquartered in St. Louis, Missouri.
Earnings Per Share
As for profitability, Cass Information Systems has a trailing twelve months EPS of $2.18.
PE Ratio
Cass Information Systems has a trailing twelve months price to earnings ratio of 20.18. Meaning, the purchaser of the share is investing $20.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.78%.
7. HealthStream (HSTM)
6.2% sales growth and 3.89% return on equity
HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs. It offers hStream, a technology platform that powers a range of healthcare workforce solutions. The company provides its solutions to customers across a range of entities within the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through its direct sales teams. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.
Earnings Per Share
As for profitability, HealthStream has a trailing twelve months EPS of $0.43.
PE Ratio
HealthStream has a trailing twelve months price to earnings ratio of 62.42. Meaning, the purchaser of the share is investing $62.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.89%.
Previous days news about HealthStream(HSTM)
- According to Zacks on Tuesday, 13 February, "One other stock from the same industry, HealthStream (HSTM Quick QuoteHSTM – Free Report) , is yet to report results for the quarter ended December 2023."
